Novavax Inc (NVAX)
8.47
+0.43
(+5.35%)
USD |
NASDAQ |
Nov 22, 16:00
8.44
-0.03
(-0.35%)
After-Hours: 20:00
Novavax Cash from Operations (Quarterly): -144.81M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -144.81M |
| June 30, 2024 | 314.27M |
| March 31, 2024 | -83.56M |
| December 31, 2023 | -176.78M |
| September 30, 2023 | -39.66M |
| June 30, 2023 | -171.94M |
| March 31, 2023 | -325.59M |
| December 31, 2022 | -117.82M |
| September 30, 2022 | -38.71M |
| June 30, 2022 | -170.90M |
| March 31, 2022 | -88.51M |
| December 31, 2021 | -342.41M |
| September 30, 2021 | -142.14M |
| June 30, 2021 | 144.41M |
| March 31, 2021 | 663.08M |
| December 31, 2020 | -128.57M |
| September 30, 2020 | -6.497M |
| June 30, 2020 | 115.63M |
| March 31, 2020 | -23.11M |
| December 31, 2019 | -23.74M |
| September 30, 2019 | -32.26M |
| June 30, 2019 | -30.01M |
| March 31, 2019 | -50.61M |
| December 31, 2018 | -45.27M |
| September 30, 2018 | -33.51M |
| Date | Value |
|---|---|
| June 30, 2018 | -39.97M |
| March 31, 2018 | -66.08M |
| December 31, 2017 | -43.40M |
| September 30, 2017 | -44.18M |
| June 30, 2017 | -12.40M |
| March 31, 2017 | -44.50M |
| December 31, 2016 | -64.55M |
| September 30, 2016 | -62.36M |
| June 30, 2016 | -62.03M |
| March 31, 2016 | -69.83M |
| December 31, 2015 | -54.75M |
| September 30, 2015 | -28.53M |
| June 30, 2015 | -12.32M |
| March 31, 2015 | -30.49M |
| December 31, 2014 | -19.77M |
| September 30, 2014 | -15.87M |
| June 30, 2014 | -10.94M |
| March 31, 2014 | -20.43M |
| December 31, 2013 | -12.26M |
| September 30, 2013 | -14.88M |
| June 30, 2013 | -7.633M |
| March 31, 2013 | -10.58M |
| December 31, 2012 | -3.252M |
| September 30, 2012 | -4.631M |
| June 30, 2012 | -6.126M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-342.41M
Minimum
Dec 2021
663.08M
Maximum
Mar 2021
-39.37M
Average
-86.03M
Median
Cash from Operations (Quarterly) Benchmarks
| Pfizer Inc | 6.714B |
| Moderna Inc | -1.566B |
| Inovio Pharmaceuticals Inc | -27.44M |
| Baxter International Inc | 253.00M |
| Halozyme Therapeutics Inc | 115.38M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 31.91M |
| Cash from Financing (Quarterly) | -0.097M |
| Free Cash Flow | -112.35M |
| Free Cash Flow Per Share (Quarterly) | -0.9174 |
| Free Cash Flow to Equity (Quarterly) | -147.24M |
| Free Cash Flow to Firm (Quarterly) | -142.63M |
| Free Cash Flow Yield | -9.00% |